Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Review Article

Authors

  • Ahmad Tavakoli Department of Virology, School of medicine, Iran University of Medical Sciences, Tehran, Iran
  • Angila Ataei Pirkooh Department of Virology, School of medicine, Iran University of Medical Sciences, Tehran, Iran
  • Helya Sadat Mortazavi Department of Virology, School of medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract:

The recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in the Middle East region in 2012. The virus is phylogenetically related to bat CoV, but other animal species like camels and goats may potentially act as an intermediate host by spreading the virus to humans. This virus is thought to cause a severe disease in patients with underlying comorbidities. Laboratory response capacity during the early stages of MERS-CoV outbreak focuses on development of virological and immunological methods for patient diagnosis, for contact tracing and for epidemiological studies into sources, modes of transmission, identification of risk groups and animal reservoirs. Current international recommendations do not support any specific therapies however there are a number of agents which were used during the SARS epidemic of 2003. It is possible that these might be active against the related coronavirus in the other hand, development of affective vaccine is crucial for preventing further pandemic of MERS-CoV. In this article we reviewed available data from MERS-CoV case reports.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

middle east respiratory syndrome coronavirus (mers-cov): a review article

the recently emerged middle east respiratory syndrome coronavirus (mers-cov) emerged in the middle east region in 2012. the virus is phylogenetically related to bat cov, but other animal species like camels and goats may potentially act as an intermediate host by spreading the virus to humans. this virus is thought to cause a severe disease in patients with underlying comorbidities. laboratory ...

full text

Update on Middle East respiratory syndrome coronavirus (MERS-CoV).

Background: Since April 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been confirmed in 8 countries: France, Italy, Jordan, Qatar, Saudi Arabia, Tunisia, United Kingdom (UK) and United Arab Emirates (UAE). Of 55 laboratory-confirmed cases, 31 were fatal for a case fatality rate of 56% (current CDC data June 7, 2013). Although no cases have been reported in the US as of June ...

full text

Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013.

Middle East Respiratory Syndrome coronavirus (MERS CoV) came to attention as an emerging pathogen causing severe respiratory illness in patients from the Middle East in September 2012. As of 14 June 2013, 58 human cases of MERS CoV infection have been confirmed, including 33 deaths (case fatality rate of 57%). MERS CoV is a beta-coronavirus, in the same family as SARS-CoV, and shares a probable...

full text

Update: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

On June 11, 2013, CDC issued interim infection prevention and control recommendations for hospitalized patients with known or suspected Middle East respiratory syndrome coronavirus (MERS-CoV) infection in U.S. hospitals. To date, no MERS-CoV cases have been reported in the United States; however, cases have been reported in eight other countries. Recent published reports have described limited ...

full text

Middle East respiratory syndrome (MERS-CoV).

Epidemiology on the ground identifies and tracks a new respiratory virus. L ast year, the infectious disease and public health communities learned of a new severe acute respiratory infection in Saudi Arabia. The stunningly rapid identification of the causative organism, the development of a diagnostic assay, online and ahead-of-print publishing, and heightened global surveillance efforts have m...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 8  issue None

pages  59- 68

publication date 2014-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023